General Information of Drug Transporter (DT)
DT ID DTD0426 Transporter Info
Gene Name SLC5A6
Transporter Name Sodium-dependent multivitamin transporter
Gene ID
8884
UniProt ID
Q9Y289
Post-Translational Modification of This DT
Overview of SLC5A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

138

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A6 Asparagine 138 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

489

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A6 Asparagine 489 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

498

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A6 Asparagine 498 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

556

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 556 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A6 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

576

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 576 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A6 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

585

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 585 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A6 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

608

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 608 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A6 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

624

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 624 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC5A6 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

625

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 625 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC5A6 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

626

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 626 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC5A6 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

634

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Serine 634 has the potential to affect its expression or activity.

  Threonine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

286

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 286 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A6 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

549

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 549 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A6 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

561

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 561 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A6 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

593

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 593 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A6 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

627

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 627 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC5A6 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

633

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Threonine 633 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

563

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Tyrosine 563 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A6 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

586

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Tyrosine 586 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A6 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

621

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A6 Tyrosine 621 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [13]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

628

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC5A6 Cystine 628 has the potential to affect its expression or activity.

S-palmitoylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [14] , [15]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

577

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at SLC5A6 Cystine 577 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A6 [16] , [17]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

599

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC5A6 Lysine 599 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC5A6_HUMAN)
2 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
3 Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
4 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
5 Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis. Anal Chem. 2015 Nov 3;87(21):10995-1006.
6 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
7 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
8 Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
9 Role of the putative N-glycosylation and PKC-phosphorylation sites of the human sodium-dependent multivitamin transporter (hSMVT) in function and regulation. Biochim Biophys Acta. 2011 Aug;1808(8):2073-80.
10 Improving depth in phosphoproteomics by using a strong cation exchange-weak anion exchange-reversed phase multidimensional separation approach. Anal Chem. 2011 Sep 15;83(18):7137-43.
11 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
12 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
13 Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
14 Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
15 Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol Cell Proteomics. 2010 Jan;9(1):54-70.
16 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
17 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.